1st Quarter - Report
THE DUBERSTEIN GROUP INC. for AMGEN INC
Client
Income
$60,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
General trade issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN CHAMPLIN | — |
Taxation/Internal Revenue Code TAX
Corporate tax issues, including repatriation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH DUBERSTEIN | — |
| DANIEL P MEYER | — |
Medicare/Medicaid MMM
Sustainable growth rate - HR 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015; S 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015; HR 2, Medicare Access and CHIP Reauthorization Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Health Issues HCR
21st Century Cures - Proposed legislation. Health reform options.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH DUBERSTEIN | — |
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.